LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX) today announced that Sharon Shacham, Ph.D., vice president of drug development of EPIX, will present “PRX-03140, A Novel and Selective 5-HT4 Agonist for the Treatment of Alzheimer’s Disease” at CBI’s Alzheimer’s Drug Development Summit on Friday, November 30, 2007 at 11:00AM EST in Arlington, Virginia.
